Latest Regulatory Risk News

Page 4 of 18
Theta Gold Mines has launched a significant capital raising initiative combining a $12 million placement, a $2 million share purchase plan, and a $32 million cornerstone investment, all accompanied by attaching options subject to shareholder approval.
Maxwell Dee
Maxwell Dee
24 Oct 2025
Newmont Corporation reported a strong third quarter in 2025, driven by higher gold prices and successful divestitures of non-core assets, enhancing liquidity and reducing debt. The company’s operational shifts and cost management reflect a strategic pivot in a volatile market.
Maxwell Dee
Maxwell Dee
24 Oct 2025
Franklin Templeton Australia has launched the Franklin Global Growth Fund – Class A, an actively managed ETF listed on the ASX aiming to outperform the MSCI World ex Australia Index with a strong ESG commitment and a 0.90% management fee.
Claire Turing
Claire Turing
23 Oct 2025
Lake Resources N.L. has released a replacement prospectus for its bonus loyalty options offer, adjusting key terms and updating its capital structure ahead of the 17 October record date. The offer aims to reward shareholders while potentially raising capital for its Kachi lithium project.
Maxwell Dee
Maxwell Dee
16 Oct 2025
EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.
Ada Torres
Ada Torres
15 Oct 2025
Global Masters Fund Limited has released its quarterly report for Q3 2025, confirming steady convertible note conversions and a healthy loan-to-value ratio, underscoring its solid financial position and compliance.
Claire Turing
Claire Turing
13 Oct 2025
Broken Hill Mines Limited has locked in a binding underwriting agreement for its BHMO Options, aiming to raise approximately A$7.5 million to accelerate drilling and development at its Broken Hill projects.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Immutep Limited has confirmed 30 mg as the optimal biological dose for its immunotherapy efti, following FDA approval of Project Optimus requirements. This milestone paves the way for the US launch of its pivotal Phase III lung cancer trial.
Ada Torres
Ada Torres
13 Oct 2025
DigitalX Limited reveals a robust A$101 million treasury portfolio dominated by Bitcoin holdings and a significant cash increase from Solana sales, underpinning its ambitious target of accumulating 2,100 Bitcoins by 2027.
Claire Turing
Claire Turing
10 Oct 2025
COG Financial Services is raising A$20 million through an institutional placement to acquire an additional 14.08% stake in Fleet Network, increasing its ownership to over 92%. This move is expected to immediately enhance earnings per share and support COG’s strategic growth in novated leasing and salary packaging.
Claire Turing
Claire Turing
9 Oct 2025
Netwealth Group Limited has reported a landmark quarter with total Funds Under Administration soaring to $120.8 billion, driven by record first-quarter net flows of $4.1 billion and strategic service expansions.
Claire Turing
Claire Turing
9 Oct 2025
Predictive Discovery and Robex Resources have agreed to merge, creating a mid-tier gold producer in West Africa with expected output surpassing 400,000 ounces annually by 2029.
Maxwell Dee
Maxwell Dee
6 Oct 2025